肝细胞胱硫醚γ裂解酶/硫化氢通过激活法尼醇X受体减轻非酒精性脂肪性肝病
研究显示非酒精性脂肪性肝病患者及高脂饮食小鼠肝内胱硫醚γ裂解酶(CSE)/硫化氢(H2S)通路下调;肝细胞特异性CSE敲除小鼠高脂饮食后肝脂沉积、胰岛素抵抗及糖异生加重,H2S供体可减轻表型,该保护作用被法尼醇X受体(FXR)敲低阻断。CSE/H2S通过硫化修饰FXR Cys138/141位点增强其活性,可能成为NAFLD治疗靶点。
要点
- NAFLD患者及高脂饮食小鼠肝内CSE/H2S通路表达下调。
- 肝细胞CSE敲除加重高脂饮食诱导的肝脂沉积、胰岛素抵抗和糖异生。
- H2S供体经FXR硫化修饰Cys138/141增强FXR活性,减轻NAFLD表型。
核心结论
- FXR硫化修饰是受肝内源性CSE/H2S影响的翻译后修饰,可能促进FXR活性并减轻NAFLD。
- 肝细胞CSE缺乏促进非酒精性脂肪性肝炎发生发展。
- H2S与FXR的相互作用可能适合作为NAFLD的药物治疗靶点。
研究设计与样本
- 研究检测了NAFLD患者肝脏、高脂饮食诱导NAFLD小鼠及油酸诱导肝细胞模型中CSE/H2S通路表达。
- 构建肝细胞特异性CSE敲除小鼠(CSELKO),与CSELoxp对照小鼠在高脂饮食下比较表型。
- 采用H2S供体及FXR敲低实验验证通路关系,并对患者肝脏进行硫化蛋白质组学分析。
主要发现
- NAFLD患者肝脏CSE蛋白表达显著下调,尤其在纤维化区域。
- 高脂饮食NAFLD小鼠及油酸诱导肝细胞模型中CSE/H2S通路亦下调。
- 高脂饮食下CSELKO小鼠较CSELoxp对照小鼠肝脂沉积增多、脂肪酸从头合成通路活性升高、肝胰岛素抵抗增加、肝糖异生能力增强。
- H2S供体治疗可减轻上述表型,而FXR敲低可阻断H2S的保护作用。
- CSELKO小鼠血清脱氧胆酸和石胆酸(FXR拮抗剂)升高,牛磺-β-鼠胆酸(FXR激活升高)降低。
关键数值与推荐
- CSE/H2S促进FXR在Cys138/141位点的硫化修饰,增强其调节脂质和葡萄糖代谢、炎症及纤维化相关靶基因表达的活性。
- 患者肝脏硫化蛋白质组学结果支持CSELKO小鼠中观察到的CSE/H2S调控作用。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Hydrogen sulfide (H2 S) plays a protective role in NAFLD. However, whether cystathionine γ lyase (CSE), a dominant H2 S generating enzyme in hepatocytes, has a role in the pathogenesis of NAFLD is currently unclear. APPROACH AND RESULTS: We showed that CSE protein expression is dramatically downregulated, especially in fibrotic areas, in livers from patients with NAFLD. In high-fat diet (HFD)-induced NAFLD mice or an oleic acid-induced hepatocyte model, the CSE/H2 S pathway is also downregulated. To illustrate a regulatory role for CSE in NAFLD, we generated a hepatocyte-specific CSE knockout mouse (CSELKO ). Feeding an HFD to CSELKO mice, they showed more hepatic lipid deposition with increased activity of the fatty acid de novo synthesis pathway, increased hepatic insulin resistance, and higher hepatic gluconeogenic ability compared to CSELoxp control mice. By contrast, H2 S donor treatment attenuated these phenotypes. Furthermore, the protection conferred by H2 S was blocked by farnesoid X receptor (FXR) knockdown. Consistently, serum deoxycholic acid and lithocholic acid (FXR antagonists) were increased, and tauro-β-muricholic acid (FXR activation elevated) was reduced in CSELKO . CSE/H2 S promoted a post-translation modification (sulfhydration) of FXR at Cys138/141 sites, thereby enhancing its activity to modulate expression of target genes related to lipid and glucose metabolism, inflammation, and fibrosis. Sulfhydration proteomics in patients' livers supported the CSE/H2 S modulation noted in the CSELKO mice. CONCLUSIONS: FXR sulfhydration is a post-translational modification affected by hepatic endogenous CSE/H2 S that may promote FXR activity and attenuate NAFLD. Hepatic CSE deficiency promotes development of nonalcoholic steatohepatitis. The interaction between H2 S and FXR may be amenable to therapeutic drug treatment in NAFLD.
引用
- Xu W, Cui C, Cui C, et al. Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor. Hepatology. 2022. PMID: 35586979. doi:10.1002/hep.32577
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。